- Home
- SIGI vs GRFS Comparison
SIGI vs GRFS Comparison
Compare SIGI & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIGI
- GRFS
- Stock Information
- Founded
- SIGI 1926
- GRFS 1940
- Country
- SIGI United States
- GRFS Spain
- Employees
- SIGI N/A
- GRFS N/A
- Industry
- SIGI Property-Casualty Insurers
- GRFS Biotechnology: Pharmaceutical Preparations
- Sector
- SIGI Finance
- GRFS Health Care
- Exchange
- SIGI Nasdaq
- GRFS Nasdaq
- Market Cap
- SIGI 5.1B
- GRFS 5.1B
- IPO Year
- SIGI N/A
- GRFS 2006
- Fundamental
- Price
- SIGI $87.09
- GRFS $6.66
- Analyst Decision
- SIGI Hold
- GRFS
- Analyst Count
- SIGI 9
- GRFS 0
- Target Price
- SIGI $98.71
- GRFS N/A
- AVG Volume (30 Days)
- SIGI 373.3K
- GRFS 1.2M
- Earning Date
- SIGI 04-30-2025
- GRFS 01-01-0001
- Dividend Yield
- SIGI 1.64%
- GRFS N/A
- EPS Growth
- SIGI N/A
- GRFS 283.33
- EPS
- SIGI 3.23
- GRFS 0.24
- Revenue
- SIGI $4,861,664,000.00
- GRFS $7,467,006,939.00
- Revenue This Year
- SIGI $6.22
- GRFS $8.45
- Revenue Next Year
- SIGI $6.68
- GRFS $7.08
- P/E Ratio
- SIGI $28.66
- GRFS $35.63
- Revenue Growth
- SIGI 14.88
- GRFS 9.41
- 52 Week Low
- SIGI $78.13
- GRFS $5.79
- 52 Week High
- SIGI $106.01
- GRFS $9.96
- Technical
- Relative Strength Index (RSI)
- SIGI 55.45
- GRFS 36.64
- Support Level
- SIGI $90.02
- GRFS $6.90
- Resistance Level
- SIGI $93.19
- GRFS $7.56
- Average True Range (ATR)
- SIGI 1.96
- GRFS 0.23
- MACD
- SIGI 0.18
- GRFS -0.10
- Stochastic Oscillator
- SIGI 51.03
- GRFS 2.96
About SIGI Selective Insurance Group Inc.
Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. Since 1977, Selective has focused its sales efforts on small businesses, offering commercial products that include workers' compensation, general liability, property, and auto insurance. Selective also has a small personal insurance segment (under 20% of total premiums), selling auto and homeowner's coverage.
About GRFS Grifols S.A.
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.